Results 61 to 70 of about 3,037 (201)

Neck pain as the problem of our time

open access: yesМедицинский совет, 2020
During life, neck pain occurs in 20-70% of people, its prevalence in the total population is 4.9%, and the annual morbidity varies from 30 to 70%. Neck pain significantly reduces the quality of life and can lead to disability.
V. A. Golovacheva   +2 more
doaj   +1 more source

Is oral lornoxicam effective in the treatment of acute migraine attacks? : a randomized-controlled study [PDF]

open access: yes, 2015
The aim of this study was to assess the efficacy of lornoxicam (LNX) in the treatment of acute migraine attacks. Material and Methods: This prospective, randomized, double-blind, placebo-controlled trial was conducted administering either LNX or placebo ...
Cabalar, Murat Cabalar   +2 more
core   +1 more source

Patch testing in fixed drug eruptions: a 20-year review. [PDF]

open access: yes, 2011
BACKGROUND: The fixed drug eruption is a common adverse drug reaction. Clear identification of the culprit drug is not always possible in the clinical setting, and oral rechallenge may induce new lesions or severe reactions.
Andrade, P   +2 more
core   +1 more source

Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery

open access: yesActa Pharmaceutica, 2015
Solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and nanoemulsion (NE) of lornoxicam (LRX) were prepared for the treatment of painful and inflammatory conditions of the skin.
Gönüllü Ümit   +4 more
doaj   +1 more source

Comparison of different postoperative paın managements in patients submitted to transperitoneal laparoscopic renal and adrenal surgery

open access: yesInternational Brazilian Journal of Urology, 2015
Purpose:We compared the effects of local levobupivacaine infiltration, intravenous paracetamol, intravenous lornoxicam treatments on postoperative analgesia in patients submitted to transperitoneal laparoscopic renal and adrenal surgery.Materials and ...
Altug Tuncel   +4 more
doaj   +1 more source

Development of SVM-based machine learning model for estimating lornoxicam solubility in supercritical solvent

open access: yesCase Studies in Thermal Engineering, 2023
This paper investigates the application of Support Vector Regression with Quadratic Kernel (QSVR) for modeling the solubility of lornoxicam in supercritical carbon dioxide.
Mingji Zhang, Wael A. Mahdi
doaj   +1 more source

Ten‐year analgesic utilization patterns and economic implications in Portugal

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 3, Page 866-881, March 2025.
Abstract Aims This study evaluated the 10‐year consumption and economic patterns of classical analgesics, adjuvants and opioids in Portugal (2012‐2022), and conducted a comparative analysis between Portugal, Spain and Denmark to explore the consumption patterns among these countries for 2022.
Nuno Duarte   +3 more
wiley   +1 more source

Peritonsillar infiltration of lidocaine Hcl versus intravenous pre-incisional lornoxicam in reducing post-tonsillectomy pain: this is a prospective, randomized, double-blinded, placebo-controlled study

open access: yesThe Egyptian Journal of Otolaryngology, 2021
Background Tonsillectomy is one of the most common procedures in otorhinolaryngology practice where analgesics are required for pain-relief especially in children.
Reham Farouk Zittoon   +3 more
doaj   +1 more source

Therapeutic Controlled Release Strategies for Human Osteoarthritis

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 2, January 14, 2025.
Therapeutic controlled release is a promising approach to treat the progressive and irreversible pathological changes in human osteoarthritis. This strategy is based on the application of recombinant molecules, drugs, and gene sequences via biocompatible materials and may provide effective and long‐lasting tools promoting the spatiotemporal delivery ...
Dan Wang   +4 more
wiley   +1 more source

Development and Characterization of Lornoxicam-Infused Ocular Gel for Effective Treatment of Ocular Inflammation in Domestic Cats

open access: yesThe Iraqi Journal of Veterinary Medicine
Lornoxicam (LOX) is a non-steroidal anti-inflammatory drug (NSAID) effective in managing ocular inflammation. Traditional delivery methods like liquid drops are cleared rapidly and may not provide sustained therapeutic levels, necessitating the ...
Riyam S Jafer, Hanan J Kassab
doaj   +1 more source

Home - About - Disclaimer - Privacy